Erlonat – 100 mg, 150 mg (1 pack / 30 tablets) – Erlotinib

Buy Erlonat 100 mg / 150 mg Erlotinib Tablets Online

Erlonat Erlotinib – 100 mg, 150 mg (1 pack / 30 tablets)

At a Glance

Brand name: Erlonat

Generic name: Erlotinib hydrochloride

Active ingredient: Erlotinib

Strengths & packs: Erlonat 100 mg (1 pack / 30 tablets); Erlonat 150 mg (1 pack / 30 tablets)

Dosage form: Oral film-coated tablets

Main indication: Advanced or metastatic non–small cell lung cancer (NSCLC) and pancreatic cancer as indicated

Therapeutic class: EGFR tyrosine kinase inhibitor

Use in therapy: Targeted first-line or subsequent therapy in EGFR-positive NSCLC and other approved settings

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Erlonat 100 mg and Erlonat 150 mg tablets are
generic erlotinib hydrochloride medicines used as targeted treatment for specific forms of cancer,
particularly advanced non–small cell lung cancer (NSCLC) and, in selected settings, pancreatic cancer.
Erlotinib is an EGFR tyrosine kinase inhibitor (TKI) that interferes with signalling pathways driving tumour growth.
This variable product listing combines both strengths so you can buy Erlonat online in either
100 mg (1 pack / 30 tablets) or 150 mg (1 pack / 30 tablets), according to your oncologist’s prescription.

Erlonat erlotinib tablets are typically prescribed as daily oral therapy. In EGFR mutation–positive NSCLC,
erlotinib tablets may be used as initial treatment or after other therapies when EGFR signalling is a key driver of disease.
The 150 mg strength is often used as a standard daily dose in many regimens, while
Erlonat 100 mg may be chosen for dose adjustments or specific clinical situations.
Because Erlonat is a generic erlotinib product, it contains the same active ingredient as branded erlotinib while offering more accessible pricing in USD.

Each Erlonat tablet contains erlotinib hydrochloride equivalent to the stated strength of erlotinib (100 mg or 150 mg).
Tablets are taken by mouth, usually once daily, and your doctor may instruct you to take Erlonat erlotinib on an empty stomach or avoid specific foods and medicines
that can affect absorption. When you order Erlonat online from Generic Meds Mart, you receive medicines supplied by licensed manufacturers and authorised distributors
that comply with recognised GMP standards. Discreet outer packaging protects your privacy while original blisters and cartons preserve all product details.

This Erlonat 100 mg / 150 mg product is intended only for patients already under the care of an oncologist who has recommended
erlotinib therapy as part of a treatment plan. Generic Meds Mart does not diagnose conditions or change treatment regimens;
the information on this page supports informed discussions with your oncology team about access to generic erlotinib tablets.

Key Uses

Erlonat erlotinib tablets are generally used for the following indications under specialist supervision:

• Treatment of locally advanced or metastatic non–small cell lung cancer (NSCLC), especially in EGFR mutation–positive tumours
• Treatment of certain patients with advanced pancreatic cancer in combination with other therapies where erlotinib is indicated
• Ongoing targeted therapy in patients who have responded to EGFR TKI treatment, as decided by their oncologist

Your specialist will determine whether Erlonat 100 mg or Erlonat 150 mg is appropriate for you, specify the daily dose and decide how long
erlotinib treatment should continue.

How Erlotinib Works in Chemotherapy

Erlotinib is a targeted anticancer agent often grouped within modern systemic chemotherapy and targeted therapy.
Erlonat contains erlotinib, an EGFR tyrosine kinase inhibitor (TKI) that blocks signalling from the epidermal growth factor receptor.
In many NSCLC tumours, activating mutations in the EGFR gene cause constant signalling and uncontrolled cell growth.

Erlonat erlotinib tablets bind to the intracellular tyrosine kinase domain of EGFR and block ATP binding,
thereby disrupting downstream signalling pathways that drive cancer cell proliferation and survival. In tumours that are highly dependent on EGFR signalling,
especially those with activating EGFR mutations, this can lead to tumour shrinkage or stabilisation.
Because erlotinib targets a molecular driver of the cancer rather than all rapidly dividing cells, its side effect profile differs from traditional cytotoxic chemotherapy,
but it still requires careful monitoring.

EGFR mutation testing is an important part of deciding whether Erlonat erlotinib is appropriate. Your oncologist will interpret these test results
and determine whether an EGFR TKI such as Erlonat is suitable for your treatment plan.

Dosage & Administration

Erlonat 100 mg and Erlonat 150 mg erlotinib tablets must always be taken exactly as prescribed by your oncologist.
Daily dosing, timing and duration of therapy depend on your diagnosis, tumour characteristics, other medicines and treatment response.

• Take Erlonat tablets by mouth with water; your doctor may instruct you to take them on an empty stomach or avoid certain foods and medicines.
• Swallow erlotinib tablets whole without crushing, splitting or chewing unless your doctor or pharmacist provides specific instructions.
• Erlonat is usually taken once daily at about the same time each day.
• Do not change your dose, skip doses or stop taking Erlonat without clear guidance from your oncology team.
• If you miss a dose, follow your doctor’s instructions; do not double the next dose unless specifically advised.

Your oncologist will schedule regular visits, blood tests and imaging studies to monitor your response to
Erlonat erlotinib therapy and to adjust doses if necessary.

Precautions

Before starting Erlonat, inform your doctor about your complete medical history and all medicines, supplements or herbal products you use. Important considerations include:

• History of lung diseases such as interstitial lung disease, pulmonary fibrosis or other chronic lung conditions
• Liver disease, kidney impairment or significant cardiovascular disease
• Previous severe skin reactions or serious gastrointestinal problems
• Use of medicines that alter stomach acidity (proton pump inhibitors, H2 blockers, antacids)
• Use of CYP3A4 inhibitors or inducers, certain antibiotics, antifungals or antiepileptics that may interact with erlotinib
• Use of anticoagulants, especially warfarin, which may require closer monitoring during Erlonat erlotinib therapy

Erlotinib may not be suitable during pregnancy, and effective contraception is usually recommended during treatment and for a period afterwards, as advised by your doctor.
Breastfeeding is often discouraged while taking Erlonat. Your oncologist will explain which precautions and monitoring tests apply to you.

Erlotinib Side Effects

Common side effects

Many patients experience side effects when starting Erlonat erlotinib tablets, especially during the first weeks of therapy. Common side effects may include:

• Acne-like skin rash, often on the face, scalp or upper trunk
• Dry, itchy or sensitive skin, sometimes with increased sun sensitivity
• Diarrhea or loose stools
• Mild nausea, vomiting or stomach discomfort
• Reduced appetite and weight loss
• Fatigue or general weakness

These effects are often manageable with supportive care, topical treatments, diet adjustments or dose modifications. You should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of erlotinib are less common but serious and require urgent medical attention. Serious reactions may include:

• New or worsening shortness of breath, cough or fever that may indicate interstitial lung disease or severe lung inflammation
• Severe or persistent diarrhea with signs of dehydration such as dizziness, fainting or reduced urine output
• Severe abdominal pain, black or bloody stools or vomiting blood, which may indicate gastrointestinal perforation or bleeding
• Signs of liver problems, including yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Severe skin reactions with widespread rash, blistering, peeling or involvement of the mouth, eyes or other mucous membranes

If you experience any of these serious symptoms while taking Erlonat 100 mg or Erlonat 150 mg, seek immediate medical care and contact your oncology team as soon as possible.

Storage

• Store Erlonat tablets at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the tablets in their original blisters and cartons until use to protect them from moisture and light.
• Keep erlotinib tablets out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired Erlonat erlotinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Erlonat 100 mg and Erlonat 150 mg erlotinib tablets at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Erlonat online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic erlotinib tablets compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your oncologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed targeted therapy with transparent conditions and professional handling of each order.

Order Now

Erlonat 100 mg and 150 mg erlotinib tablets are prescription-only anticancer medicines and must be used strictly under the supervision of an oncologist.
Before you order Erlonat online, ensure that you have a valid prescription or written treatment plan specifying erlotinib, the required strength and the intended duration of therapy.

Select the prescribed strength — Erlonat 100 mg (1 pack / 30 tablets) or Erlonat 150 mg (1 pack / 30 tablets) —
choose the appropriate quantity, add Erlonat to your cart and complete the secure checkout process. Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your oncology team.

FAQ about Erlonat Erlotinib tablets